Showing results (41-50 of 115) with videos related to

Sort By:
Pageof 12
Frontiers in Public Health|February 8, 2024
Review of Israel's action and response during the COVID-19 pandemic and tabletop exercise for the evaluation of readiness and resilience-lessons learned 2020-2021Khitam Muhsen, Dani Cohen, Aharona Glatman-Freedman, et al.
Vaccine|April 2, 2011
Sero-prevalence of mumps antibodies in subpopulations subsequently affected by a large scale mumps epidemic in IsraelKhitam Muhsen, Tamy Shohat, Yair Aboudy, et al.
Journal of Clinical Medicine|October 14, 2020
Enhanced Humoral Immune Responses against Toxin A and B of <i>Clostridium difficile</i> is Associated with a Milder Disease ManifestationWasef Na'amnih, Yehuda Carmeli, Valeria Asato, et al.
Frontiers in Pediatrics|June 5, 2023
Relationships of the gut microbiome with cognitive development among healthy school-age childrenYelena Lapidot, Maayan Maya, Leah Reshef, et al.
Scientific Reports|August 6, 2021
Convulsions in children hospitalized for acute gastroenteritisMoti Iflah, Eias Kassem, Uri Rubinstein, et al.
Vaccine|April 21, 2019
Validation of parental reports of rotavirus vaccination of their children compared to the national immunization registryShayel Bercovich, Emilia Anis, Eias Kassem, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|November 6, 2015
Change in incidence of clinic visits for all-cause and rotavirus gastroenteritis in young children following the introduction of universal rotavirus vaccination in IsraelKhitam Muhsen, Gabriel Chodick, Sophy Goren, et al.
JAMA Network Open|July 7, 2022
Association of BNT162b2 Vaccine Third Dose Receipt With Incidence of SARS-CoV-2 Infection, COVID-19-Related Hospitalization, and Death Among Residents of Long-term Care Facilities, August to October 2021Khitam Muhsen, Nimrod Maimon, Amiel Yaron Mizrahi, et al.
Vaccine|March 16, 2010
The seroepidemiology of Bordetella pertussis in Israel--Estimate of incidence of infectionPamela Rendi-Wagner, Joshua Tobias, Larisa Moerman, et al.
JAMA Network Open|June 7, 2021
Assessment of Effectiveness of 1 Dose of BNT162b2 Vaccine for SARS-CoV-2 Infection 13 to 24 Days After ImmunizationGabriel Chodick, Lilac Tene, Tal Patalon, et al.
Pageof 12